Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €72.53 EUR
Change Today -0.079 / -0.11%
Volume 0.0
As of 6:11 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

davita healthcare partners i (TRL) Snapshot

Open
€72.44
Previous Close
€72.61
Day High
€72.93
Day Low
€72.29
52 Week High
04/27/15 - €78.96
52 Week Low
05/7/14 - €48.02
Market Cap
15.6B
Average Volume 10 Days
62.4
EPS TTM
--
Shares Outstanding
215.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DAVITA HEALTHCARE PARTNERS I (TRL)

davita healthcare partners i (TRL) Related Businessweek News

View More BusinessWeek News

davita healthcare partners i (TRL) Details

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates in two divisions, Kidney Care and HealthCare Partners. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. The company offers outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers, as well as patient and physician focused integrated health care delivery and management services. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2014, the company provided dialysis and administrative services in the United States through a network of 2,179 outpatient dialysis centers in 46 states and the District of Columbia serving approximately 173,000 patients; operated or provided administrative services to a total of 91 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 7,200 patients; and integrated care management services for approximately 837,300 members under its care in southern California, central and south Florida, southern Nevada, central New Mexico, and central Arizona. It also provides acute inpatient dialysis services in approximately 1,000 hospitals and related laboratory services in the United States. The company was formerly known as DaVita Inc. and changed its name to DaVita HealthCare Partners Inc. in November 2012. DaVita HealthCare Partners Inc. was founded in 1994 and is headquartered in Denver, Colorado.

57,900 Employees
Last Reported Date: 02/26/15
Founded in 1994

davita healthcare partners i (TRL) Top Compensated Officers

Co-Chairman, Chief Executive Officer and Chie...
Total Annual Compensation: $1.2M
Interim Chief Financial Officer and Chief Acc...
Total Annual Compensation: $650.0K
Chief Executive Officer of International and ...
Total Annual Compensation: $1.0M
Chief Executive Officer of Kidney Care Divisi...
Total Annual Compensation: $800.0K
Chief Legal Officer
Total Annual Compensation: $650.0K
Compensation as of Fiscal Year 2014.

davita healthcare partners i (TRL) Key Developments

DaVita Kidney Care Announcement Regarding Atlanta Lawsuit

DaVita Kidney Care announced the next step in an agreement in principle for a settlement in an Atlanta-based case, which previously was announced on April 15. The lawsuit was brought by private attorneys regarding allegations of medication wastage from 2003 to 2010.

DaVita HealthCare Partners Inc. Reports Consolidated Unaudited Earnings Results for First Quarter Ended March 31, 2015; Revised Earnings Guidance for 2015

DaVita HealthCare Partners Inc. reported consolidated unaudited earnings results for first quarter ended March 31, 2015. For the quarter, the company reported total net revenues of $3,287,965,000 compared with $3,042,776,000 for the same period last year. Operating loss was $64,156,000 compared with operating income of $441,225,000 for the same period last year. Loss before income taxes was $162,081,000 compared with income before income taxes of $336,588,000 for the same period last year. Net loss attributable to DaVita HealthCare Partners Inc. was $110,617,000 or $0.52 diluted per share compared with net income attributable to DaVita HealthCare Partners Inc. of $183,289,000 or $0.85 diluted per share for the same period last year. Net cash provided by operating activities was $410,089,000 compared with $419,107,000 for the same period last year. Additions of property and equipment was $121,421,000 compared with $126,562,000 for the same period last year. Adjusted operating income excluding an accrual of an estimated loss contingency was $431,000 compared with $441,000 for the same period last year. Adjusted net income attributable to DaVita HealthCare Partners Inc. excluding an accrual of an estimated loss contingency was $187,000 or $0.86 diluted per share compared with $183,000 or $0.85 diluted per share for the same period last year. Net debt, net of cash and cash equivalents was $7,502,000 compared with $7,555,000 for the same period last year. The company is updating its consolidated operating income for 2015 to now be in the range of $1.800 billion to $1.925 billion. Previous consolidated operating income guidance for 2015 was in the range of $1.750 billion to $1.900 billion. Consolidated operating cash flow for 2015 to be in the range of $1.500 billion to $1.700 billion. 2015 effective tax rate attributable to DaVita HealthCare Partners Inc. to now be approximately 39.0% to 40.0% previous the company expected 2015 effective tax rate attributable to DaVita HealthCare Partners Inc. was 39.5% to 40.5%.

DaVita HealthCare Partners Inc. Announces Closing of its Cash Tender Offer for the 2020 Notes and Calls for Redemption of Untendered 2020 Notes

DaVita HealthCare Partners Inc. announced the closing of its previously announced tender offer to purchase for cash (the Tender Offer) any and all of its outstanding 6 5/8% Senior Notes due 2020 (the 2020 Notes). The Tender Offer expired at 5:00 p.m., Eastern Time, on April 20, 2015 (the Expiration Time). At the Expiration Time, valid tenders had been received with respect to approximately $599.6 million of the $775 million aggregate principal amount of the 2020 Notes outstanding. The Company has accepted for payment all 2020 Notes validly tendered prior to the Expiration Time pursuant to the Tender Offer. On April 21, 2015, such tendering holders will receive the purchase price in the amount of $1,053.19 for each $1,000 principal amount of 2020 Notes tendered, plus accrued and unpaid interest to, but not including, the date hereof. In addition, the Company will accept any additional 2020 Notes properly tendered by means of the guaranteed delivery procedures provided. In accordance with the indenture, on April 20, 2015, the Company issued an irrevocable notice of redemption with respect to all outstanding 2020 Notes that were not tendered in the Tender Offer. The redemption date is May 20, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRL:GR €72.53 EUR -0.079

TRL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Apollo Medical Holdings Inc $6.94 USD -0.56
Fresenius Medical Care AG & Co KGaA €74.71 EUR +0.81
Fresenius SE & Co KGaA €53.74 EUR +0.18
IPC Healthcare Inc $47.42 USD -0.83
Team Health Holdings Inc $58.87 USD -1.00
View Industry Companies
 

Industry Analysis

TRL

Industry Average

Valuation TRL Industry Range
Price/Earnings 41.5x
Price/Sales 1.3x
Price/Book 3.6x
Price/Cash Flow 17.2x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAVITA HEALTHCARE PARTNERS I, please visit www.davita.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.